Scott Centea

2020

In 2020, Scott Centea earned a total compensation of $841.4K as SVP and GM, Peripheral Vascular at AngioDynamics.

Compensation breakdown

Non-Equity Incentive Plan$84,943
Option Awards$230,710
Salary$261,747
Stock Awards$239,009
Other$24,959
Total$841,368

Centea received $261.7K in salary, accounting for 31% of the total pay in 2020.

Centea also received $84.9K in non-equity incentive plan, $230.7K in option awards, $239K in stock awards and $25K in other compensation.

Rankings

In 2020, Scott Centea's compensation ranked 9,303rd out of 13,090 executives tracked by ExecPay. In other words, Centea earned more than 28.9% of executives.

ClassificationRankingPercentile
All
9,303
out of 13,090
29th
Division
Manufacturing
3,972
out of 5,621
29th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
504
out of 799
37th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
311
out of 495
37th
Industry
Surgical and Medical Instruments and Apparatus
201
out of 313
36th

Pay ratio

Scott Centea's Pay$841,368
Median Employee's Pay$72,130
Pay Ratio

12

to 1

In 2020, the annual total compensation of Scott Centea was $841,368.

The annual total compensation of the median employee at AngioDynamics was $72,130.

The ratio of Scott Centea's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on September 3, 2020.

Centea's colleagues

We found five more compensation records of executives who worked with Scott Centea at AngioDynamics in 2020.

2020

James Clemmer

AngioDynamics

Chief Executive Officer

2020

Michael Greiner

AngioDynamics

Chief Financial Officer

2020

Stephen Trowbridge

AngioDynamics

Chief Financial Officer

2020

David Helsel

AngioDynamics

SVP, Global Operations and R&D

2020

Brent Boucher

AngioDynamics

Former SVP, Oncology

News

You may also like